Bladder Cancer Pharmaceutical and Healthcare Analysis InformationSummary
Bladder cancer occurs in tissues of the urinary bladder. Symptoms include blood or blood clots in the urine, frequent urination, lower back pain on one side of the body and burning during urination. Risk factors for bladder cancer include smoking, exposure to substances such as rubber, certain dyes and textiles, paint, and hairdressing supplies, diet rich in fried meats and fat, old age, sex and color, certain parasitic infections. Treatment of bladder cancer includes chemotherapy, surgery, biological therapy and radiation therapy.
GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2593468-bladder-cancer-pipeline-review-h2-2017
Pharmaceutical and Healthcare latest pipeline guide Bladder Cancer - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Bladder Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Bladder Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Bladder Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 10, 53, 52, 5, 63, 12 and 1 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 7, 2, 10 and 3 molecules, respectively.
Bladder Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
- The pipeline guide provides a snapshot of the global therapeutic landscape of Bladder Cancer (Oncology).
- The pipeline guide reviews pipeline therapeutics for Bladder Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Bladder Cancer (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Bladder Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Bladder Cancer (Oncology)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Bladder Cancer (Oncology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Bladder Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Content: Key Points
Table of Contents 2
Bladder Cancer - Overview 9
Bladder Cancer - Therapeutics Development 10
Bladder Cancer - Therapeutics Assessment 36
Bladder Cancer - Companies Involved in Therapeutics Development 55
Bladder Cancer - Drug Profiles 112
Bladder Cancer - Dormant Projects 894
Bladder Cancer - Discontinued Products 901
Bladder Cancer - Product Development Milestones 903
ACCESS REPORT @ https://www.wiseguyreports.com/reports/2593468-bladder-cancer-pipeline-review-h2-2017
Get in touch:
Wise Guy Reports is part of the Wise Guy Consultants analysis Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
WISE GUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bladder Cancer Pharmaceutical and Healthcare Analysis Information here
News-ID: 852288 • Views: 194
More Releases from WISE GUY RESEARCH CONSULTANTS PVT LTD
Vertical Farming Market 2019- Global Industry Analysis, Size, Share, Growth, Tre …
New Study On “2019-2025 Vertical Farming Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database Report Overview: The Global Vertical Farming Market valued USD 2.3 billion in 2018 and expected to grow at a CAGR of 8% to reach a market value of USD 4.2 billion by 2026. Market Dynamics: The growing demand for precision farming owing to declining arable land other natural resources is the primary
Cystitis Market 2019 Global Analysis, Opportunities And Forecast To 2025
WiseGuyReports have announced the addition of a new report titled “2019 Global and Regional Cystitis Market Research Report Forecast 2025”. Report Overview: Cystitis is usually not severe and may be awkward if left untreated, but may lead to complications. Bacterial infection most often causes cystitis. Cystitis is described as inflammation of the bladder, which is typically caused by bladder infection, according to the National Health Service. In the majority of cases, mild
Global Acute Renal Failure Market Industry Outlook, Demand, Key Manufacturers an …
Report Overview: Acute renal failure usually happens when kidneys are damaged suddenly. Normally, the kidneys filter the blood and remove waste and excess salt and water. Acute kidney failure is when the kidneys suddenly stop working. Acute renal failure can be due to many different causes. The damage that leads to ARF may be caused by not enough blood flowing through kidneys, an injury direct to kidneys, and blockage in ureters.
Global Dialysis Market 2019 Key Players, Share, Trends, Sales, Segmentation and …
An Research report has been added to the portfolio of WiseGuyReports titled, “2019 Global and Regional Dialysis Market Research Report Forecast 2025”. Report Overview: The global dialysis market size was worth $ 73 billion in2018 and is forecasted to reach $ 105 billion by 2026, at a CAGR of 4.7% during the forecast period. In medicine, dialysis is the process of removing excess water, solutes, and toxins from the blood in people whose
More Releases for Bladder
Bladder Cancer Therapeutics Market : How the Bladder Cancer Therapeutics Market …
As per stats released by the World Cancer Research Fund International, around 430,000 new cases of bladder cancer were diagnosed in 2012, with bladder cancer being the ninth-most common cancer. The bladder holds urine before it leaves the body during urination. The disease in which cancerous cells form in the tissues of the bladder is known as bladder cancer. Download Free PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/239 There
Global Bladder Scanners Sales Market Report 2018
This report studies the global Bladder Scanners market status and forecast, categorizes the global Bladder Scanners market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). A bladder scanner is a medical device that utilizes ultrasound to noninvasively measure the amount of
Bladder Cance rMarket entry and expansion strategies
MarketResearchReports.Biz adds “Global Bladder Cancer Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Bladder Cancer and the growth estimates for the forecasted period. Bladder cancer is a rapidly evolving field in which new developments are constantly influencing the market landscape. The Dynamic Market Forecast is designed to help clients stay abreast of the latest news in the bladder
Bladder Scanners Market Research Report 2011-2023
Browse full table of contents and data tables at : https://www.reportsandmarkets.com/reports/global-bladder-scanners-market-research-report-2011-2023-1476292 Summary A bladder scanner is a medical device that utilizes ultrasound to noninvasively measure the amount of urine in the bladder or to determine how much urine remains in the bladder after urination as a way to measure residual levels. Request a sample copy at : https://www.reportsandmarkets.com/sample-request/global-bladder-scanners-market-research-report-2011-2023-1476292 The type of scanner is a niche ultrasound system that provides fast
Bladder Cancer Market Research Report : Forecast 2025
Bladder cancer is a urologic malignancy occurring in the tissues of the urinary bladder. It is characterized by the uncontrolled, rapid growth of cells arising from the epithelial lining and can be proliferating to the muscular wall of urinary bladder. The bladder or urinary bladder is a hollow organ located in the pelvis (lower abdomen) which stores the urine drained from kidney. It is connected to the kidney by ureters,
National Bladder Health Week November 14-18
National Bladder Health Week is November 14-18, 2011. The National Association For Continence (NAFC), as part of its Bladder Health Awareness campaign, is hosting free, online activities throughout Bladder Health Week to educate participants about prevention, treatment and management options for urinary incontinence. It is estimated that over 25 million adult Americans routinely experience loss of bladder control. Because age is a risk factor for such health problems, the prevalence